Skip to main content
. 2023 Jan 4;2023:4540287. doi: 10.1155/2023/4540287

Table 4.

The analysis of the markers of severity for COVID-19 patients with different ACE gene allelic variants.

ACE gene polymorphism P value
D/D D/I I/I
Agea (years) 63 (48–66) 69 (56–71) 66 (46–68) 0.232
Lymphocytic countb (μl) 0.88 ± 0.36α 1.25 ± 0.38β 1.8 ± 0.34μ <0.001
CRPa (mg/L) 63α (36–81) 33β (22–42) 24β (23–31) 0.001
D-dimera (mg/L) 0.79 (40–1.18) 0.52 (37–89) 0.78 (29–2.14) 0.417
Oxygen saturationb (%) 77.8 ± 10.2α 85.5 ± 8.1β 84.8 ± 5.1β 0.028

Statistically significant results. aData were expressed as median and IQ. bData were expressed mean ± SD. Significant difference between α and β. Significant difference between α and μ. Significant difference between β and μ.